DIVISLAB(DIVISLAB)
DIVISLAB
No analyst coverage available for this stock.
Divi's Laboratories Ltd. is a pharmaceutical company based in India, known for its significant role in the global pharmaceuticals industry as a leading manufacturer of active pharmaceutical ingredients (APIs) and intermediates. Founded in 1990, the company focuses on the development and production of generic and custom synthesis APIs, which are crucial components in the manufacture of various medicines. Divi's Laboratories serves a diverse range of industries including generic pharmaceuticals, contact manufacturing of APIs, nutraceuticals, and custom synthesis of active ingredients for innovators. The company's strategic investments in state-of-the-art R&D facilities and production capabilities underscore its commitment to quality and compliance with international standards. It has a robust presence in international markets, with a substantial portion of its revenue generated from exports, highlighting its global market impact. Divi's plays a pivotal role in both the supply chain of pharmaceutical companies and in contributing to public health through the provision of essential drug components.